ISSN: 0270-9139
Journal Home
Journal Guideline
Hepatology Q1 Unclaimed
Hepatology is a journal indexed in SJR in Medicine (miscellaneous) and Hepatology with an H index of 403. It has a price of 1900 €. It has an SJR impact factor of 5,011 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 5,011.
Hepatology focuses its scope in these topics and keywords: hepatitis, virus, liver, patients, chronic, cells, hepatocellular, factor, infection, growth, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy: Open Choice
Type of publications:
Publication frecuency: -
1900 €
Inmediate OANPD
Embargoed OA0 €
Non OAMetrics
5,011
SJR Impact factor403
H Index482
Total Docs (Last Year)1570
Total Docs (3 years)16638
Total Refs13572
Total Cites (3 years)1042
Citable Docs (3 years)7.92
Cites/Doc (2 years)34.52
Ref/DocOther journals with similar parameters
Nature Biomedical Engineering Q1
Journal of Thoracic Oncology Q1
Annual Review of Clinical Psychology Q1
Lancet Digital Health, The Q1
Journal of Experimental Medicine Q1
Compare this journals
Aims and Scope
Best articles by citations
1204 Early HCV kinetics in immunosuppressed patients undergoing antiviral therapy: OLT vs. HIV-HCV coinfected vs. normal patients
View moreMutations in nonstructural protein 5A gene and response to interferon in hepatitis C virus genotype 2 infection
View moreAspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease
View moreHepatitis C in asymptomatic blood donors
View moreThe role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension
View moreAdvances in bioartificial liver devices
View moreLiver failure in children with hepatitis A
View moreInduction of interleukin-6 by interferon alfa and its abrogation by a serine protease inhibitor in patients with chronic hepatitis C
View moreViral kinetics and hepatitis C
View moreContribution of the murine mdr1a P-glycoprotein to hepatobiliary and intestinal elimination of cationic drugs as measured in mice with anmdr1agene disruption
View moreThe Persistence of Hepatitis A IgM Antibody After Acute Clinical Hepatitis A
View moreQuantitative analysis of anti-hepatitis C virus antibody-secreting B cells in patients with chronic hepatitis C
View moreThe role of TT virus infection in acute viral hepatitis
View moreResults of retransplantation for recurrent hepatitis C
View moreHepatitis C virus 1b, cirrhosis, and hepatocellular carcinoma
View moreRandomized, Double-Blind, Placebo-Controlled Trial of Interferon Alfa2a With and Without Amantadine as Initial Treatment for Chronic Hepatitis C
View moreHepatitis C virus genotype 1b and risk of hepatocellular carcinoma
View moreCritical flicker frequency for quantification of low-grade hepatic encephalopathy
View moreEffects of blood volume restitution following a portal hypertensive-related bleeding in anesthetized cirrhotic rats
View moreDetermining the fate of hepatic cells by lineage tracing: Facts and pitfalls
View moreCigarette smoking and hepatic lesions in patients with chronic hepatitis C
View morePeginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1
View moreA phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis
View moreL-ornithine L-aspartate in bouts of overt hepatic encephalopathy
View more
Comments